Although m6A is firmly established as a central regulator of CSC functions, emerging data from NSUN7 in glioblastoma and TET2 in leukemia highlight the potential significance of m5C in maintaining CSC properties and promoting tumor progression. The gene discussed is TET2; the disease is leukemia.